Caption Management, LLC Chinook Therapeutics, Inc. Transaction History
Caption Management, LLC
- $10.8 Billion
- Q3 2025
A detailed history of Caption Management, LLC transactions in Chinook Therapeutics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 45,000 shares of KDNY stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
45,000Holding current value
$0% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding KDNY
# of Institutions
3Shares Held
234KCall Options Held
0Put Options Held
0About CHINOOK THERAPEUTICS, INC.
- Ticker KDNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,896,300
- Description
- Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...